News & Events

2020

Kyowa Hakko Bio Establishes New Facility in Thailand to Supply Human Milk Oligosaccharides Worldwide

November 6, 2020PRWeb.com

KYOWA HAKKO BIO CO. LTD. (Kyowa Hakko Bio), a subsidiary of Kirin Holdings Company, Limited (Kirin Holdings), has announced that it will establish a new facility to manufacture human milk oligosaccharides (HMOs) in Thailand. Kyowa Hakko Bio decided on the move with expectations of a future increase in global demand for HMOs. This move further expands its global footprint to consolidate its position as a global specialty fermentation manufacturer. Read more »

The Latest Breakthrough Approach in Immunity – IMMUSE™ Enters the U.S. Market

September 28, 2020New York, NY, USA

International health ingredient manufacturer Kyowa Hakko Bio Co., Ltd. (Kyowa Hakko) and parent company Kirin Holdings Co., Ltd., (Kirin Holdings) announce the launch of its novel dietary supplement ingredient IMMUSE™, delivering a new approach for broad range immune support. Read more »